Tech Company Inital Public Offerings
Flexion Therapeutics IPO
Flexion Therapeutics, based in Burlington, debuted as a public company on 2/12/2014.
Transaction Overview
Company Name
Announced On
2/12/2014
Transaction Type
IPO
Amount
$65,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10 Mall Rd. 301
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
Flexion Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Clayman
Chief Medical Officer
Scott Kelley
Vice President
Christina Willwerth
VP - Bus. Development
Adam Muzikant
VP - General Counsel
Mark Levine
VP - Operations
Daniel Leblanc
VP - Regulatory Affairs
Kerry Wentworth
Browse more venture capital transactions:
Prev: 2/12/2014: Uplogix venture capital transaction
Next: 2/12/2014: ClearPath venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs